Stock IMMUTEP LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Immutep Ltd Australian S.E.

Equities

AU000000PRR9

Chart calendar Immutep Ltd

489fa181bc9.CvYq9q3M9JRunJmrJeV562b3-MDtIW1E7SBW8XQ-q4M.aKQTgOy0jvUs18P_VdwapBGxjKKaEgV3nmkVuyN0_s1E22DP_aGOoTrrrQ~27d6b6a71628083e6e32218406a8ef53

Upcoming events on Immutep Ltd

15/05/2024 European Society for Medical Oncology Meeting
31/05/2024 American Society of Clinical Oncology Annual Meeting
28/08/2024 Q4 2024 Earnings Release (Projected)
20/02/2025 Q2 2025 Earnings Release (Projected)
27/08/2025 Q4 2025 Earnings Release (Projected)
19/02/2026 Q2 2026 Earnings Release (Projected)

Past events on Immutep Ltd

28/02/2024 04:09 am Q2 2024 Earnings Release
16/02/2024 07:00 am ShareCafe Hidden Gems Webinar
06/02/2024 10:10 am Euroz Hartleys Healthcare Forum
30/01/2024 03:02 am December 2023 Sales and Revenue Release - Activities Report
08/01/2024 JPMorgan Healthcare Conference
15/11/2023 08:30 pm Jefferies London Healthcare Conference
14/11/2023 Immuno-Oncology Europe Conference
09/11/2023 09:00 pm Baird Biotech Discovery Series
03/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 595
03/11/2023 09:30 pm Society for Immunotherapy of Cancer Meeting - Abstract Number : 595
01/11/2023 AusBiotech Conference
31/10/2023 05:30 pm September 2023 Sales and Revenue Release - Activities Report
25/10/2023 Wilsons Drug and Device Healthcare Conference
24/10/2023 05:00 am Annual General Meeting
23/10/2023 European Society for Medical Oncology Congress - Poster No: 1987TiP
23/10/2023 European Society for Medical Oncology Congress - Poster No: 1042P
23/10/2023 02:30 am European Society for Medical Oncology Congress
21/10/2023 12:35 pm European Society for Medical Oncology Congress - Abstract No: 2174
27/09/2023 12:15 am Cantor Global Healthcare Conference
13/09/2023 11:20 am E&P Small Caps Conference

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million AUD		Released
Forecast
Spread 		7,49
0,00
- 		16,5
13,0
26.47%		0,00
4,95
- 		6,76
4,04
67.13%		5,20
6,15
-15.41%
3,19

EBITDA
Million AUD		Released
Forecast
Spread 		-18,3
-7,55
-142.58%		0,00
0,00
- 		-17,6
-19,1
7.93%		-30,1
-35,5
15.3%		-37,8
-41,3
8.49%
-47,0

EBIT
Million AUD		Released
Forecast
Spread 		-20,2
-15,0
-34.9%		-12,3
-15,6
20.94%		-19,7
-24,1
18.34%		-32,1
-36,9
12.9%		-39,9
-44,2
9.86%
-47,4

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread 		-18,3
-18,5
0.96%		-13,5
-15,4
12.69%		-29,9
-30,8
2.83%		-32,2
-36,8
12.45%		-39,9
-43,4
8.08%
-45,9

Net income
Million AUD		Released
Forecast
Spread 		-18,3
-12,8
-43.47%		-13,5
-15,4
12.47%		-29,9
-30,8
2.83%		-32,2
-36,8
12.45%		-39,9
-43,4
8.08%
-45,2

EPS
AUD		Released
Forecast
Spread 		-0,06
-0,03
-90%		-0,03
0,00
-1020%		-0,05
-0,04
-13.93%		-0,04
-0,04
12.63%		-0,04
-0,04
-3%
-0,04

Announcement Date20/08/1925/08/2030/08/2131/08/2229/08/23-

Quarterly results

Fiscal PeriodJune 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million AUD		Released
Forecast
Spread





0,00
0,00
- 		0,00
1,08
- 		2,08
1,40
48.57%		3,91
3,20
22.07%


2,62
3,23
-19.05%		4,11
2,10
95.73%
0,67

EBITDA
Million AUD		Released
Forecast
Spread





-9,34
-9,40
0.62%		-8,24
-9,70
15%		-15,0
-15,1
0.99%		-15,7
-16,2
3.21%
-19,7


-21,8


-23,8


-26,0

EBIT
Million AUD		Released
Forecast
Spread 		-5,37
-5,10
-5.37%		-6,94
-9,52
27.09%		-10,4
-12,3
15.38%		-9,26
-13,5
31.62%		-16,8
-15,1
-11.65%		-15,9
-17,9
11.42%		-20,6
-19,0
-8.69%		-19,3
-22,6
14.77%		-21,2
-23,9
11.13%
-26,2

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread 		-5,95
-5,10
-16.69%		-7,52
-9,57
21.42%		-19,8
-14,1
-41.17%		-10,1
-15,3
34.43%		-16,3
-15,1
-8.1%		-15,9
-18,0
11.44%		-20,6
-19,2
-7.18%		-19,3
-21,2
9.06%		-21,2
-23,7
10.48%
-25,3

Net income
Million AUD		Released
Forecast
Spread 		-5,95
-5,10
-16.7%		-7,52
-9,52
21%		-19,8
-14,1
-41.17%		-10,1
-15,3
34.43%		-16,3
-15,1
-8.1%		-15,9
-18,1
11.69%		-20,6
-12,8
-60.78%		-19,3
-21,9
11.98%		-21,2
-23,7
10.48%
-25,0

EPS
AUD		Released
Forecast
Spread





-0,04
-0,04
4.25%		-0,01
-0,03
52%		-0,02
-0,02
0%		-0,02
-0,02
15.91%		-0,02
-0,02
-2.61%


-0,02
-0,02
14.76%
-0,02

Announcement Date20/02/2025/08/2023/02/2130/08/2124/02/2331/08/2224/02/2329/08/2327/02/24-

Upcoming sector events for Immutep Ltd

29/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
29/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
29/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
30/04/2024 01:35 am QIAGEN N.V.: Q1 2024 Earnings Release
30/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
01/05/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Immutep Ltd

27/04/2024 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
27/04/2024 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 10:30 am BB BIOTECH AG: Q1 2024 Earnings Release
26/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
26/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
26/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 04:30 pm MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 11:30 am PURETECH HEALTH PLC: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. IMM Stock
  4. Stock
  5. Calendar Immutep Ltd